東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Global health partnerships = the pha...

Wang, Mei-Ling, (1960-)

FindBook

Google Book

Amazon

博客來

Global health partnerships = the pharmaceutical industry and BRICA /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Global health partnerships/ Mei-Ling Wang.
其他題名:	the pharmaceutical industry and BRICA /
作者:	Wang, Mei-Ling,
出版者:	Basingstoke [England] ;Palgrave Macmillan, : 2009.,
面頁冊數:	1 online resource (x, 193 p.)
附註:	Description based on print version record.
內容註:	Global health partnerships: an introduction -- Modern pharmaceuticalindustry: history, current position and challenges -- The BRICAs in global pharmaceutical provision -- Global health partnerships between multinationals and the BRICAs: a planting strategy.
標題:	Pharmaceutical industry. -
電子資源:	http://link.springer.com/10.1057/9780230582873access to fulltext (Palgrave)
ISBN:	0230582877 (electronic bk.)

Global health partnerships = the pharmaceutical industry and BRICA /
Wang, Mei-Ling,1960-

Global health partnershipsthe pharmaceutical industry and BRICA /[electronic resource] :Mei-Ling Wang. - Basingstoke [England] ;Palgrave Macmillan,2009. - 1 online resource (x, 193 p.)

Description based on print version record.

Includes bibliographical references (p. 167-187) and index.

Global health partnerships: an introduction -- Modern pharmaceuticalindustry: history, current position and challenges -- The BRICAs in global pharmaceutical provision -- Global health partnerships between multinationals and the BRICAs: a planting strategy.

The challenges facing multinational pharmaceutical companies have never been greater and the need for an innovative solution has never beenmore urgent. The decrease of profits in pharmaceuticalmarkets in developed countries, the increasing pressure of price controls from regulators, the rapid increase of epidemics, pandemics and chronic illnesses, and a contracted global economy have led to a pessimistic forecast of the pharmaceutical industry in developed countries. On the other hand, the prospects for pharmaceutical development have never been better in BRICAs (Brazil, Russia, India,China and African countries). This book provides a new strategy to resolve the imbalance in global pharmaceutical supply and demand chains by proposing a new global health partnershipmodel between the stakeholders in developed countries and those in BRICAs. This strategy aims to multiply the strengths of all stakeholders and create a sustainable growth scenario that benefits all populations.

ISBN: 0230582877 (electronic bk.)

Standard No.: 10.1057/9780230582873doiSubjects--Topical Terms:

630829
Pharmaceutical industry.
Index Terms--Genre/Form:

542853
Electronic books.

LC Class. No.: RA401.A1 / W36 2009eb

Dewey Class. No.: 362.17/82

Global health partnerships = the pharmaceutical industry and BRICA /
LDR:02282cmm 2200301 a 45 001 911279
003 OCoLC
005 20110114
006 m d
007 cr cnu---unuuu
008 231227s2009 enk sb 001 0 eng d
020 $a 0230582877 (electronic bk.)
020 $a 9780230582873 (electronic bk.)
024 7 $a 10.1057/9780230582873 $2 doi
035 $a (OCoLC)314821483
035 $a ocn314821483
035 $a 911279
040 $a UKPGM $b eng $c UKPGM $d YDXCP $d N $t $d EBLCP
049 $a APTA
050 4 $a RA401.A1 $b W36 2009eb
082 0 4 $a 362.17/82 $2 22
100 1 $a Wang, Mei-Ling, $d 1960- $3 1097573
245 1 0 $a Global health partnerships $h [electronic resource] : $b the pharmaceutical industry and BRICA / $c Mei-Ling Wang.
260 $a Basingstoke [England] ; $a New York : $c 2009. $b Palgrave Macmillan,
300 $a 1 online resource (x, 193 p.)
500 $a Description based on print version record.
504 $a Includes bibliographical references (p. 167-187) and index.
505 0 $a Global health partnerships: an introduction -- Modern pharmaceuticalindustry: history, current position and challenges -- The BRICAs in global pharmaceutical provision -- Global health partnerships between multinationals and the BRICAs: a planting strategy.
520 $a The challenges facing multinational pharmaceutical companies have never been greater and the need for an innovative solution has never beenmore urgent. The decrease of profits in pharmaceuticalmarkets in developed countries, the increasing pressure of price controls from regulators, the rapid increase of epidemics, pandemics and chronic illnesses, and a contracted global economy have led to a pessimistic forecast of the pharmaceutical industry in developed countries. On the other hand, the prospects for pharmaceutical development have never been better in BRICAs (Brazil, Russia, India,China and African countries). This book provides a new strategy to resolve the imbalance in global pharmaceutical supply and demand chains by proposing a new global health partnershipmodel between the stakeholders in developed countries and those in BRICAs. This strategy aims to multiply the strengths of all stakeholders and create a sustainable growth scenario that benefits all populations.
650 0 $a Pharmaceutical industry. $3 630829
650 0 $a Pharmaceutical policy. $3 630828
650 0 $a Public health $x International cooperation. $3 775752
650 0 $a World health. $3 553735
655 7 $a Electronic books. $2 lcsh $3 542853
856 4 0 $3 Palgrave Connect $u http://link.springer.com/10.1057/9780230582873 $z access to fulltext (Palgrave)